Table 1.
Demographic and Clinical Characteristics and Financial Toxicity Among Bladder Cancer Patients
| Overall N= (%) | Financial toxicity, n=33 (24%) | No financial toxicity, n=105 (76%) | p | ||
|---|---|---|---|---|---|
| Age (years) | <65 | 61 (44%) | 21 (64%) | 40 (38%) | 0.02 |
| ≥65 | 77 (56%) | 12 (36%) | 65 (62%) | ||
| Gender | Female | 34 (25%) | 8 (24%) | 26 (25%) | 1.00 |
| Male | 104 (75%) | 25 (76%) | 79 (75%) | ||
| Race | Black | 14 (10%) | 8 (24%) | 6 (6%) | 0.01 |
| Hispanic | 1 (1%) | 0 (0%) | 1 (1%) | ||
| White | 123 (89%) | 25 (76%) | 98 (93%) | ||
| BMI (kg/m2) | 18.5–24.9 | 41 (30%) | 8 (24%) | 33 (31%) | 0.55 |
| 25–29.9 | 52 (38%) | 11 (33%) | 41 (39%) | ||
| 30–34.9 | 24 (17%) | 8 (24%) | 16 (15%) | ||
| >35 | 21 (15%) | 6 (18%) | 15 (14%) | ||
| Marital Status | Single | 14 (10%) | 3 (9%) | 11 (10%) | 0.95 |
| Married/living with partner | 95 (69%) | 22 (69%) | 73 (70%) | ||
| Divorced/separated/widowed | 28 (20%) | 7 (22%) | 21 (20%) | ||
| Education | Eighth grade or less | 4 (3%) | 1 (3%) | 3 (3%) | 0.01 |
| Some high school | 9 (7%) | 4 (12%) | 5 (4%) | ||
| High school degree/GED | 45 (33%) | 13 (39%) | 32 (31%) | ||
| Some college or technical school | 33 (24%) | 11 (33%) | 22 (21%) | ||
| Some graduate/masters | 28 (20%) | 4 (12%) | 24 (23%) | ||
| Completed postgraduate/professional | 19 (14%) | 0 (0%) | 19 (18%) | ||
| Insurance | Medicaid | 10 (7%) | 3 (9%) | 7 (7%) | 0.75 |
| Medicare only | 19 (14%) | 5 (16%) | 14 (14%) | ||
| Private | 100 (74%) | 22 (69%) | 78 (76%) | ||
| Self Pay | 6 (4%) | 2 (6%) | 4 (4%) | ||
| Work for Pay | Yes | 38 (27%) | 11 (33%) | 27 (26%) | 0.38 |
| No | 100 (73%) | 22 (67%) | 78 (74%) | ||
| Bladder Cancer Clinical T Stage | Non-invasive (Tis, Ta, T1) | 69 (51%) | 21 (68%) | 48 (46%) | 0.04 |
| Invasive (T2–T4) | 66 (49%) | 10 (32%) | 56 (54%) | ||
| Previous intravesical chemotherapy | Yes | 42 (30%) | 12 (36%) | 30 (29%) | 0.40 |
| No | 96 (70%) | 21 (64%) | 75 (71%) | ||
| Postoperative readmissions | Yes | 29 (33%) | 6 (27%) | 23 (34%) | 0.61 |
| No | 60 (67%) | 16 (73%) | 44 (66%) | ||
| Charlson Comorbidity Index | Median (IQR) | 5 (4, 7) | 4 (3, 6) | 5 (4, 7) | 0.02 |
| Time from cancer diagnosis (yr) | Median (IQR) | 0.4 (0.1, 1.2) | 0.5 (0.3, 1.0) | 0.4 (0.1, 1.3) | 0.93 |
| Distance traveled (miles) | Median (IQR) | 62 (32, 119) | 62 (33, 121) | 62 (31, 117) | 0.35 |
| Number of prior cystoscopies | Median (IQR) | 1 (1, 2) | 1 (1, 1) | 1 (1, 2) | 0.59 |
| Number of prior TURBTs | Median (IQR) | 1 (1, 1) | 1 (1, 1) | 1 (1, 1) | 0.14 |